Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis

(1) Background: Ciprofloxacin (CPF) is widely used for the treatment of cystic fibrosis, including pediatric patients, but its pharmacokinetics is poorly studied in this population. Optimal CPF dosing in pediatric patients may be affected by gene polymorphism of the enzymes involved in its biotransf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zyryanov, Sergey K., Ushkalova, Elena A., Kondratyeva, Elena I., Butranova, Olga I., Kondakova, Yulia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139162/
https://www.ncbi.nlm.nih.gov/pubmed/35625789
http://dx.doi.org/10.3390/biomedicines10051050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139162/
https://www.ncbi.nlm.nih.gov/pubmed/35625789
http://dx.doi.org/10.3390/biomedicines10051050

Ejemplares similares